J. Michael Carmena - 22 Dec 2021 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: Principal Executive Officer, Director
Issuer ticker: SMTI
Reported as of: 22 Dec 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Dec 2021, 15:30:27 UTC
Prior SEC filing: 20 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ J. Michael Carmena

Key filing fact

J. Michael Carmena filed Form 4 for Sanara MedTech Inc. (SMTI) on 23 Dec 2021.

Key facts

This page summarizes J. Michael Carmena's Form 4 filing for Sanara MedTech Inc. (SMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Dec 2021, 15:30.

Change

Previous filing in this sequence was filed on 20 Dec 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value: $0
Shares: +3,549
Change %: +19%
Price: $0.000000
Shares after: 22,113
Date: 22 Dec 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Long-Term Incentive Plan, as amended and restated. The shares will vest on January 3, 2022.